XML 22 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Adoption of ASU 2016-13
As Reported under CECL
Common Stock
Common Stock
As Reported under CECL
Retained Earnings
Retained Earnings
Adoption of ASU 2016-13
Retained Earnings
As Reported under CECL
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
As Reported under CECL
Beginning balance (in shares) at Dec. 31, 2022       17,940,283 17,940,283          
Beginning balance at Dec. 31, 2022 $ 260,355 $ (3,851) $ 256,504 $ 218,280 $ 218,280 $ 48,516 $ (3,851) $ 44,665 $ (6,441) $ (6,441)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation $ 3,763     $ 3,763            
Stock options exercised (in shares) 10,950     10,950            
Stock options exercised $ 93     $ 93            
Restricted stock units vested (in shares)       390,320            
Repurchase of shares in settlement of restricted stock units (in shares)       (32,271)            
Repurchase of shares in settlement of restricted stock units (504)     $ (504)            
Net (loss) income 21,498         21,498        
Other comprehensive income (loss) (2,804)               (2,804)  
Ending balance (in shares) at Sep. 30, 2023       18,309,282            
Ending balance at Sep. 30, 2023 278,550     $ 221,632   66,163     (9,245)  
Beginning balance (in shares) at Jun. 30, 2023       18,296,365            
Beginning balance at Jun. 30, 2023 273,749     $ 220,702   59,607     (6,560)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation $ 992     $ 992            
Stock options exercised (in shares) 0                  
Restricted stock units vested (in shares)       17,148            
Repurchase of shares in settlement of restricted stock units (in shares)       (4,231)            
Repurchase of shares in settlement of restricted stock units $ (62)     $ (62)            
Net (loss) income 6,556         6,556        
Other comprehensive income (loss) (2,685)               (2,685)  
Ending balance (in shares) at Sep. 30, 2023       18,309,282            
Ending balance at Sep. 30, 2023 $ 278,550     $ 221,632   66,163     (9,245)  
Beginning balance (in shares) at Dec. 31, 2023 18,369,115     18,369,115            
Beginning balance at Dec. 31, 2023 $ 288,152     $ 222,036   70,575     (4,459)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation 4,695     $ 4,695            
Issuance of common stock in business combination (in shares) [1]       13,497,091            
Issuance of common stock in business combination [1] $ 214,380     $ 214,380            
Stock options exercised (in shares) 82,900     82,900            
Stock options exercised $ 716     $ 716            
Restricted stock units vested (in shares) [2]       280,051            
Restricted stock units vested [2] 825     $ 825            
Repurchase of shares in settlement of restricted stock units (in shares)       (86,730)            
Repurchase of shares in settlement of restricted stock units (968)     $ (968)            
Net (loss) income (11,339)         (11,339)        
Other comprehensive income (loss) $ 1,603               1,603  
Ending balance (in shares) at Sep. 30, 2024 32,142,427     32,142,427            
Ending balance at Sep. 30, 2024 $ 498,064     $ 441,684   59,236     (2,856)  
Beginning balance (in shares) at Jun. 30, 2024       18,547,352            
Beginning balance at Jun. 30, 2024 293,219     $ 224,006   75,700     (6,487)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation $ 2,804     $ 2,804            
Issuance of common stock in business combination (in shares) 13,579,454     13,497,091 [1]            
Issuance of common stock in business combination [1] $ 214,380     $ 214,380            
Stock options exercised (in shares) 1,500                  
Restricted stock units vested (in shares) [2]       141,263            
Restricted stock units vested [2] $ 825     $ 825            
Repurchase of shares in settlement of restricted stock units (in shares)       (44,779)            
Repurchase of shares in settlement of restricted stock units (341)     $ (341)            
Net (loss) income (16,464)         (16,464)        
Other comprehensive income (loss) $ 3,631               3,631  
Ending balance (in shares) at Sep. 30, 2024 32,142,427     32,142,427            
Ending balance at Sep. 30, 2024 $ 498,064     $ 441,684   $ 59,236     $ (2,856)  
[1] Includes $1.3 million related to replacement awards granted in connection with the business combination for the three and nine months ended September 30, 2024 (Refer to Note 2 - Business Combinations).
[2] The three and nine months ended September 30, 2024 include $825 thousand related to the acceleration of 123,123 replacement awards issued in connection with the business combination for non-continuing directors, executives and employees (Refer to Note 2 - Business Combinations).